C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235763 Expression vector involved in proliferation or replication, or immune protection of HSV; or transcriptional and/or translational products of target sequence
11/25/2004	US20040235746 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
11/25/2004	US20040235743 Soluble zalpha11 cytokine receptors
11/25/2004	US20040235741 Human papilloma virus treatment
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235721 Relates to polynucleotides coding for PPVO viral genome, to fragments of polynucleotides coding for PPVO genome and to polynucleotides coding for individual open reading frames of PPVO viral genome; for treatment of viral, non-viral infections, proliferative, inflammatory, autoimmune diseases
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235199 Method for fabricating a nanoarray using the self-assembly of supramolecules and staining of metals
11/25/2004	US20040235176 Reporter gene-containing plasmid which is convertible to T-Vector and the preparation method thereof
11/25/2004	US20040235175 Method for transfection of rna using electrical pulses
11/25/2004	US20040235173 Production of host cells containing multiple integrating vectors by serial transduction
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235169 Lentiviral expression vector for use as gene transfer tool in genetic engineerning; heterologous gene expression and tissue engineering; bioreactors
11/25/2004	US20040235164 Antisense nucleotide sequences for use in the prevention and treatment of asthmatic disorders; gene expression ihibition
11/25/2004	US20040235159 Using nutrient broth comprising cell proliferative agents and mouse embryonic fibroblasts to propagating pluripotent stem cells for use in cell replacement therapies
11/25/2004	US20040235157 Transgenic cell line for use as tools in identification of signal transduction modulators; diagnostic assay comprising enhanced shelf life
11/25/2004	US20040235156 Therapeutic mixture comprising interferons and chimeric immunoglobulins for use in activation of immune response and treatment, diagnosis and prevention of cancer; immunotherapy; tissue targeted therapy
11/25/2004	US20040235148 Reaction vessel and reaction vessel holding mechanism
11/25/2004	US20040235146 Receptor-ligand systems used for analysis; high throughput assay
11/25/2004	US20040235143 Device for delivering a gene or drug solution into a cell
11/25/2004	US20040235140 Transgenic microorganism for use as bioreactor for expression of heterologous genes and proteins; antigen production and vaccine development
11/25/2004	US20040235135 Preparing viral nucleotide sequences where immune response-inducing antigen sequences are repositioned in the position closest to the 3' end and viral replication limiting factor gene is repositioned away from 3' promoter; for use in generating vaccine to treat and prevent viral infectious diseases
11/25/2004	US20040235134 Newcastle disease virus infectious clones, vaccines and new diagnostic assays
11/25/2004	US20040235133 Large scale production of packaged alphavirus replicons
11/25/2004	US20040235132 Helper cell comprising coronavirus permissive cell, replicon RNA and helper RNA: for use in producing assembled coronavirus particles which comprise heterologous RNA sequences, is able to infect cells and is unable to complete viral replication in absence of helper RNA; heterologous gene expression
11/25/2004	US20040235129 KDEL receptor inhibitors
11/25/2004	US20040235127 PUFA polyketide synthase systems and uses thereof
11/25/2004	US20040235125 Novel cyclodextrin glucanotransferase (cgtase), obtained from<I> bacillus agaradherens</I> (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
11/25/2004	US20040235123 Transgenic escherichia for use as bioreactor in fermentation of alpha-lipoic acid for use in animal feeds, medicines and cosmetics
11/25/2004	US20040235122 Process for the production of L-amino acids using strains of the enterobacteriaceae family
11/25/2004	US20040235121 Bacterial orgins of replication for use as replication componet of expression vector; cloning and expression of foreign genes in cells
11/25/2004	US20040235120 Method for producing vitamin b12
11/25/2004	US20040235117 Fusion protein comprised of t umor necrosis factor, cartilage oligomeric and cartliage matrix protein domains for use in identifying modulator for treatment of infections, autoimmue, cell proliferative, neurodegenerative and inflammatory diseases
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235112 Enzymatic polypeptide for use in detection of modulators for prevention a nd treatment of inflammatory, cell proliferative and autoimmune diseases; enzyme inhibitors
11/25/2004	US20040235108 Immunoglobulin which competitively binds tetrameric form of the alpha-folate receptor for use in treatment and prevention of cell proliferfative disorders; immunotherapy
11/25/2004	US20040235107 Biosynthesis of TA antibiotic
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235105 Sorbitol dehydrogenase, gene encoding the same and use thereof
11/25/2004	US20040235103 In vitro transfromation; polypeptides; genetic engineering
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235101 Genetic circuit clocked latch
11/25/2004	US20040235099 Expression vector comprising glucose isomerase promoter for use as regulatory tool in multiple heterologous gene transfer and expression
11/25/2004	US20040235098 Sulfotransferase sequence variants
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040235094 Regulation of human ptpase-like protein
11/25/2004	US20040235093 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and uses thereof
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235091 Preparing protease resistant, bioactive amino acid sequences for use as therapeutic peptides; biodrugs; mimetics
11/25/2004	US20040235090 Fermenting somatotropin from transgenic escherichia and using dipeptidyl aminopeptidase to modify terminal; bioreactors and heterologous gene expression
11/25/2004	US20040235088 Process for the production of ergosterol and its intermediate products using recombinant yeasts
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235079 Identifying modulators associated with heme independent inhibition of soluble guanylyl cyclase for use in treatment of infection, hypertension and cardiovascular disorders
11/25/2004	US20040235077 Luciferase and methods for measuring intracellular ATP using the same
11/25/2004	US20040235074 Methods for the treatment or prevention of immune disorders using anti-CD40 antibodies
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235069 isolated polypeptide have specified sequence which has an activity to cause permeation of ions
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004	US20040235060 Biosensor for defecting chemical agents
11/25/2004	US20040235058 ULBP antibodies
11/25/2004	US20040235043 Molecular computing elements: gates and flip-flops
11/25/2004	US20040235042 Preparing DNA immobilized microarray comprising obtaining spherical plastic particles holding avidin, incubate with labeled nucleotide sequences, attach, immobilize on solid support
11/25/2004	US20040235038 Using single-stranded conformational polymorphisms to identify mutation which lead to cardiovascular disorders; identifying modulator for treatment of cardiac disorders
11/25/2004	US20040235036 Solid support for analyzing genetic material from more than one individual; determining the frequency of a particular genetic trait within a population; corelating mutation, allele or polymorphism to particular physiological condition
11/25/2004	US20040235035 Method for producing a synthetic gene or other DNA sequence
11/25/2004	US20040235034 Method of recovering nucleic acids and kit for recovering nucleic acids
11/25/2004	US20040235031 Using catalytic, self-cleaving RNA species to cleave connective tissue growth factor (CTGF) and decrease scarring during healing; wound healing agent
11/25/2004	US20040235029 In vitro translation system
11/25/2004	US20040235025 Apparatus for separating and purifying nucleic acid and method for separating and purifying nucleic acid
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040235017 Comprises nucleotide sequences coding cyclooxygenase for use in identifying pain preventative and antiinflammatory agents; more specific cyclooxygenases reduced side effects
11/25/2004	US20040235013 Method of sequencing by hybridization of oligonucleotide probes
11/25/2004	US20040235011 Production of multimeric proteins
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234999 Biopolymer mixtures for use in the inhibition of gene expression; RNA interference and gene therapy
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234988 Scoring system for the prediction of cancer recurrence
11/25/2004	US20040234987 Method for identifying reading frame mutations
11/25/2004	US20040234986 Comprises nucleotide sequences coding acyl CoA:diacylglycerol transferase for use in prediciting fat content of fat and milk
11/25/2004	US20040234984 Using direct repeats associated with vector insertion as tools to remove preferential genomic/plasmid sequences; genetic engineering and heterologous gene transfer/expression
11/25/2004	US20040234981 Method of determining dna base sequence
11/25/2004	US20040234977 Comprises enzymatic polypeptide for use as diagnostic indicator of injury or disease associated with brain, liver and muscle tissue; immunoassay
11/25/2004	US20040234975 Expression vectors comprising nucleotide sequences coding decaprenyl diphosphate synthase for transformation and propagation in escherichia; bioreactors and heterologous gene expresssion; free radical scavanger
11/25/2004	US20040234974 Comprises nucleotide sequences for treating nervous system disorders via controlling reversible expression of proteins having a synaptic transmission-controlling activity; tissue engineering and neurotoxin therapeutics
11/25/2004	US20040234973 Using cytosine methylation to diagnose cancer disorders
11/25/2004	US20040234969 Using cytochrome p450 gene expression as diagnostic indicator of steroid responsiveness; identifying modulators for treatment and prevention of skin and allergic disorders
11/25/2004	US20040234965 Novel pathways involved in epigenetic memory
11/25/2004	US20040234960 Evaluating methylation status of nucleotide sequences; treat sequences and convert cytosine to uracil, amplify segment comprising 5-methyl cytosine, hybridize with peptide nucleic acid and oligomers, evaluate methylation and quantify amplification products
11/25/2004	US20040234959 Truncated bard1 protein, and its diagnostic and therapeutic uses
11/25/2004	US20040234953 Viral nucleotide sequences coding envelope proteins for use in preparing antibodies for prevention and treatment of autoimmune disorders
11/25/2004	US20040234951 Chimeric chains that coding for proteins that induce effects directed against viruses
11/25/2004	US20040234948 Simian viral gene transfer construct comprising and capable of displaying vesicular stomatitis virus glycoprotein sequences for use as tool in generating transgenic embryonic stem cell; tissue engineering
11/25/2004	US20040234947 Cells for detection of influenza and parainfluenza viruses
11/25/2004	US20040234586 Compositions and methods for enhancing nucleic acid transfer into cells

1 ... 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 ... 4023